Imunon, Inc. (IMNN) reporting calendar
Imunon, Inc. files periodic reports with the SEC as IMNN on Nasdaq. Atlas tracks 62 filed reports for this issuer, each linked to its original EDGAR accession.
- Next window
- 16 Jul 2026 – 8 Sep 2026
- Latest report
- 10-Q
- Period ended
- 31 Mar 2026
- Filed
- 12 May 2026
- Reports on record
- 62
How this window is derived. Derived from this issuer's own filing history: 9 periods at a median 91-day cadence, filed a median 43 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.
Open IMNN market profile
Latest filing on SEC EDGAR ↗
Pharmaceutical Preparations reporting datesAll Nasdaq reporting dates
Filed periodic reports
| Form | Period ended | Filed | Lag | SEC accession |
|---|---|---|---|---|
| 10-Q | 31 Mar 2026 | 12 May 2026 | 42 days | 0001493152-26-022416 |
| 10-K | 31 Dec 2025 | 31 Mar 2026 | 90 days | 0001493152-26-013850 |
| 10-Q | 30 Sep 2025 | 13 Nov 2025 | 44 days | 0001493152-25-022120 |
| 10-Q | 30 Jun 2025 | 5 Aug 2025 | 36 days | 0001493152-25-011598 |
| 10-Q | 31 Mar 2025 | 12 May 2025 | 42 days | 0001641172-25-009572 |
| 10-K | 31 Dec 2024 | 27 Feb 2025 | 58 days | 0001493152-25-008460 |
| 10-Q | 30 Sep 2024 | 7 Nov 2024 | 38 days | 0001493152-24-043931 |
| 10-Q | 30 Jun 2024 | 14 Aug 2024 | 45 days | 0001493152-24-031916 |
| 10-Q | 31 Mar 2024 | 13 May 2024 | 43 days | 0001493152-24-018795 |
| 10-K | 31 Dec 2023 | 28 Mar 2024 | 88 days | 0001493152-24-011616 |
| 10-Q | 30 Sep 2023 | 14 Nov 2023 | 45 days | 0001493152-23-040803 |
| 10-Q | 30 Jun 2023 | 10 Aug 2023 | 41 days | 0001493152-23-027457 |
| 10-Q | 31 Mar 2023 | 11 May 2023 | 41 days | 0001493152-23-016299 |
| 10-K | 31 Dec 2022 | 30 Mar 2023 | 89 days | 0001493152-23-009604 |
| 10-Q | 30 Sep 2022 | 14 Nov 2022 | 45 days | 0001493152-22-031641 |
| 10-Q | 30 Jun 2022 | 15 Aug 2022 | 46 days | 0001493152-22-022599 |
| 10-Q | 31 Mar 2022 | 16 May 2022 | 46 days | 0001493152-22-013522 |
| 10-K | 31 Dec 2021 | 31 Mar 2022 | 90 days | 0001493152-22-008277 |
| 10-Q | 30 Sep 2021 | 15 Nov 2021 | 46 days | 0001493152-21-028358 |
| 10-Q | 30 Jun 2021 | 12 Aug 2021 | 43 days | 0001493152-21-019448 |
| 10-Q | 31 Mar 2021 | 14 May 2021 | 44 days | 0001493152-21-011406 |
| 10-K | 31 Dec 2020 | 19 Mar 2021 | 78 days | 0001493152-21-006382 |
| 10-Q | 30 Sep 2020 | 16 Nov 2020 | 47 days | 0001493152-20-021447 |
| 10-Q | 30 Jun 2020 | 14 Aug 2020 | 45 days | 0001493152-20-015690 |
| 10-Q | 31 Mar 2020 | 15 May 2020 | 45 days | 0001493152-20-008927 |
| 10-K | 31 Dec 2019 | 25 Mar 2020 | 85 days | 0001493152-20-004717 |
| 10-Q | 30 Sep 2019 | 14 Nov 2019 | 45 days | 0001493152-19-017489 |
| 10-Q | 30 Jun 2019 | 14 Aug 2019 | 45 days | 0001493152-19-012615 |
| 10-Q | 31 Mar 2019 | 15 May 2019 | 45 days | 0001493152-19-007214 |
| 10-K | 31 Dec 2018 | 29 Mar 2019 | 88 days | 0001493152-19-004184 |
| 10-Q | 30 Sep 2018 | 14 Nov 2018 | 45 days | 0001493152-18-016176 |
| 10-Q | 30 Jun 2018 | 14 Aug 2018 | 45 days | 0001493152-18-011631 |
| 10-Q | 31 Mar 2018 | 11 May 2018 | 41 days | 0001437749-18-009535 |
| 10-K | 31 Dec 2017 | 27 Mar 2018 | 86 days | 0001437749-18-005539 |
| 10-Q | 30 Sep 2017 | 14 Nov 2017 | 45 days | 0001437749-17-019215 |
| 10-Q | 30 Jun 2017 | 14 Aug 2017 | 45 days | 0001437749-17-014732 |
| 10-Q | 31 Mar 2017 | 12 May 2017 | 42 days | 0001437749-17-008847 |
| 10-K | 31 Dec 2016 | 24 Mar 2017 | 83 days | 0001437749-17-005235 |
| 10-Q | 30 Sep 2016 | 10 Nov 2016 | 41 days | 0001437749-16-041670 |
| 10-Q | 30 Jun 2016 | 15 Aug 2016 | 46 days | 0001437749-16-037387 |
Source: SEC EDGAR company submissions for CIK 0000749647. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.